Zhitong Finance App News, Jingfang Pharmaceutical-B (02595.HK) issued an announcement. Updated data from the Phase II trial of GFH375 single-agent treatment of KRASG12D mutant non-small cell lung cancer appeared in the oral report at the World Lung Cancer Conference (WCLC) held in Seoul this year on September 14, local time.

Zhitongcaijing · 3d ago
Zhitong Finance App News, Jingfang Pharmaceutical-B (02595.HK) issued an announcement. Updated data from the Phase II trial of GFH375 single-agent treatment of KRASG12D mutant non-small cell lung cancer appeared in the oral report at the World Lung Cancer Conference (WCLC) held in Seoul this year on September 14, local time.